| Product Code: ETC7641951 | Publication Date: Sep 2024 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Ireland continued to rely heavily on the USA, UK, Germany, Metropolitan France, and Serbia for therapeutic vaccine imports. The market concentration, as measured by the Herfindahl-Hirschman Index (HHI), remained very high, indicating limited diversification among suppliers. However, the compound annual growth rate (CAGR) for the period 2020-2024 was negative at -4.18%, with a significant decline in the growth rate from 2023 to 2024 at -30.16%. These figures suggest potential challenges and opportunities for the therapeutic vaccines market in Ireland, requiring a strategic approach to address market dynamics.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Therapeutic Vaccines Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Therapeutic Vaccines Market Revenues & Volume, 2022 & 2032F |
3.3 Ireland Therapeutic Vaccines Market - Industry Life Cycle |
3.4 Ireland Therapeutic Vaccines Market - Porter's Five Forces |
3.5 Ireland Therapeutic Vaccines Market Revenues & Volume Share, By Type, 2022 & 2032F |
3.6 Ireland Therapeutic Vaccines Market Revenues & Volume Share, By Therapeutic Vaccines, 2022 & 2032F |
4 Ireland Therapeutic Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases in Ireland leading to a higher demand for therapeutic vaccines |
4.2.3 Rising awareness about preventive healthcare measures and immunization programs in the country |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements and lengthy approval processes for therapeutic vaccines in Ireland |
4.3.2 High development costs associated with researching and manufacturing therapeutic vaccines |
4.3.3 Limited accessibility to advanced healthcare services in certain regions of Ireland |
5 Ireland Therapeutic Vaccines Market Trends |
6 Ireland Therapeutic Vaccines Market, By Types |
6.1 Ireland Therapeutic Vaccines Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Ireland Therapeutic Vaccines Market Revenues & Volume, By Type, 2022 - 2032F |
6.1.3 Ireland Therapeutic Vaccines Market Revenues & Volume, By Peptide Therapeutic Vaccine, 2022 - 2032F |
6.1.4 Ireland Therapeutic Vaccines Market Revenues & Volume, By Cell Therapeutic Vaccine, 2022 - 2032F |
6.1.5 Ireland Therapeutic Vaccines Market Revenues & Volume, By Nucleic Acid Therapeutic Vaccine, 2022 - 2032F |
6.2 Ireland Therapeutic Vaccines Market, By Therapeutic Vaccines |
6.2.1 Overview and Analysis |
6.2.2 Ireland Therapeutic Vaccines Market Revenues & Volume, By Oncotherapy, 2022 - 2032F |
6.2.3 Ireland Therapeutic Vaccines Market Revenues & Volume, By Hepatitis B, 2022 - 2032F |
6.2.4 Ireland Therapeutic Vaccines Market Revenues & Volume, By Tuberculosis, 2022 - 2032F |
6.2.5 Ireland Therapeutic Vaccines Market Revenues & Volume, By Herpes Simplex Virus, 2022 - 2032F |
6.2.6 Ireland Therapeutic Vaccines Market Revenues & Volume, By Others, 2022 - 2032F |
7 Ireland Therapeutic Vaccines Market Import-Export Trade Statistics |
7.1 Ireland Therapeutic Vaccines Market Export to Major Countries |
7.2 Ireland Therapeutic Vaccines Market Imports from Major Countries |
8 Ireland Therapeutic Vaccines Market Key Performance Indicators |
8.1 Percentage increase in vaccination coverage rates for targeted diseases in Ireland |
8.2 Number of clinical trials and research studies conducted on therapeutic vaccines in Ireland |
8.3 Rate of adoption of innovative technologies and treatment methods in the field of therapeutic vaccines |
9 Ireland Therapeutic Vaccines Market - Opportunity Assessment |
9.1 Ireland Therapeutic Vaccines Market Opportunity Assessment, By Type, 2022 & 2032F |
9.2 Ireland Therapeutic Vaccines Market Opportunity Assessment, By Therapeutic Vaccines, 2022 & 2032F |
10 Ireland Therapeutic Vaccines Market - Competitive Landscape |
10.1 Ireland Therapeutic Vaccines Market Revenue Share, By Companies, 2025 |
10.2 Ireland Therapeutic Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here